Serous uterine cancer is an exception, with five-year survival rates of 35% to 50% for stage 1 or 2 cancer. Now, researchers ...

"This phase 2 randomized placebo-controlled trial ... Survival for early-stage endometrial cancer remains high at more than 80%; however, survival rates for advanced uterine cancer decrease ...

MSK surgeons pioneered an approach for determining where gynecologic cancers are likely to spread first, allowing them to remove a much smaller number of lymph nodes and reduce the complications of ...

Background Endometrial cancer is the most common gynecologic ... Multivariate analyses revealed Trop-2 overexpression and advanced FIGO stage to be independent prognostic factors for poor DFS ...

GSK’s Jemperli is designed to help the body’s immune system find and attack cancer cells, and is already approved in the EU ...

The risk and incidence of cancer among people under 50 is also on the rise, according to American Cancer Society.

Overall, surgical de-escalation in gynecologic oncology increased from 2004 to 2020, with a growing shift toward minimally ...